Enlivex ENLV 深 沪
交易中 08-28 10:43:03 美东时间
1.485
+0.010
+0.68%
华盛通- 最 高1.55
- 今 开1.50
- 成交量 9.23万股
- 最 低 1.4107
- 昨 收 1.475
- 总市值 2596.59万
- 52周最高 27.15
- 市盈率 静 0.00
- 换手率 0.53%
- 52周最低 1.39
- 委 比 -48.15%
- 总股本 1748.55万
- 历史最高 673.50
- 量 比 2.73
- 振 幅 9.44%
- 历史最低 1.4107
- 每 手 1
- 风险率 4.55%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Enliven’s Lead Drug Could Disrupt The Leukemia Treatment Market, Analyst Says
Enliven Therapeutics Inc. (NASDAQ:ELVN) drew an Outperform rating from William Blair on Tuesday as the firm initiated coverage, citing the potential for lead drug candidate ELVN-001 to reshape treatment of chronic myeloid leukemia (CML). ELVN-001 Shows Positive Phase 1 Data Enliven Therapeutics’ lea...
08-19 01:58
美股前瞻 | 美财长称明日与伊达成协议！道指、标普500指数期货齐创历史新高；光通信概念盘前飙升；SpaceX盘后放榜
美财长称明日与伊达成协议！道指、标普500指数期货齐创历史新高；光通信概念盘前飙升，Lumentum劲升13%；SpaceX盘后放榜！未来指引将“大于”业绩本身？>>
08-04 20:13
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
Enlivex Announces Trading Volume On Rain Protocol Reaches $860M
Enlivex Ltd. (NASDAQ:ENLV, "Enlivex" or the "Company")), a quality longevity company powered by a prediction markets treasury, today provided an update on the Rain protocol trading metrics. Trading volume on the Rain protocol reached $860 million, and experienced a substantial increase of 622% betw...
07-30 20:05
Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones
Enlivex Ltd. will host a live webinar on July 30, 2026, at 10:00 AM ET to discuss its recent private placement, Rain protocol milestones, and clinical progress for Allocetra™, including its new FDA RMAT designation. The webinar will cover the rationale and value creation potential of the private placement, updates on the Rain protocol, and recent clinical advancements for Allocetra™ in treating knee osteoarthritis. Registration is available at [l...
07-29 12:00
Enlivex Secures $400 Million Premium-Priced Private Placement Backed by RAIN Tokens
Enlivex ( ($ENLV) ) just unveiled an update. On July 28, 2026, Enlivex announce...
07-28 20:27
Enlivex plunges in pre-market trade after announcing $400M private placement
Enlivex (ENLV) said on Tuesday that it intends to launch a private placement of $400M ordinary shares at a price of $5.00 per share for subscription amounts funded in U.S. dollars, USDT, or USD Coin a...
07-28 20:20
Enlivex shares are trading higher after the company announced its RAIN token holdings.
Enlivex shares are trading higher after the company announced its RAIN token holdings.
07-20 21:01
Enlivex reports $1.1B RAIN token treasury; NAV at $66.16/share
Enlivex (ENLV) reported a net asset value of $66.16 per ordinary share as of July 18, 2026. The company held 79.55B RAIN tokens as of July 18, 2026. Enlivex valued its RAIN token treasury at approxima...
07-20 20:21
Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra™ in Age-Related Knee Osteoarthritis
FDA grants RMAT designation to Allocetra™ for age-related knee osteoarthritis, acknowledging its potential to address an unmet medical need. The designation enables intensive FDA engagement, potentially expediting approval. Enlivex's Phase I/IIa trial showed significant improvements in knee pain and function, leading to a Phase IIb trial enrolling 182 patients. Osteoarthritis affects millions, with limited treatment options, highlighting the sign...
07-13 12:00
